你即將離開本站

並前往https://www.pharmaceutical-technology.com/data-insights/rgx-314-abbvie-net-present-value/

Risk Adjusted Net Present Value: What is the current valuation ...

RGX-314 is a gene therapy commercialized by AbbVie, with a leading Phase III program in Choroidal Neovascularization.

確定！ 回上一頁

查詢 「AbbVie stock」的人也找了：

  1. abbvie產品
    2.
  2. Ms stock
    3.
  3. MO stock
    4.
  4. U.S. stock
    5.
  5. Lilly stock price
    6.
  6. Marlboro stock
    7.
  7. GILD stock
    8.
  8. Lays stock
    9.